125 related articles for article (PubMed ID: 2148228)
1. Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy.
Uchiyama T; Matsumoto M; Kobayashi N
Thromb Res; 1990 Sep; 59(6):955-65. PubMed ID: 2148228
[TBL] [Abstract][Full Text] [Related]
2. Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.
Takahashi H; Tsuda A; Tatewaki W; Wada K; Niwano H; Shibata A
Thromb Res; 1989 Sep; 55(6):727-35. PubMed ID: 2528845
[TBL] [Abstract][Full Text] [Related]
3. Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer.
Nanninga PB; van Teunenbroek A; Veenhof CH; Büller HR; ten Cate JW
Thromb Haemost; 1990 Nov; 64(3):361-4. PubMed ID: 1710832
[TBL] [Abstract][Full Text] [Related]
4. Alterations in coagulation and fibrinolysis during sepsis.
Kidokoro A; Iba T; Fukunaga M; Yagi Y
Shock; 1996 Mar; 5(3):223-8. PubMed ID: 8696988
[TBL] [Abstract][Full Text] [Related]
5. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
Fujiwara Y; Tagami S; Kawakami Y
J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454
[TBL] [Abstract][Full Text] [Related]
6. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
7. Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
Tóth NK; Csanádi Z; Hajas O; Kiss A; Nagy-Baló E; Kovács KB; Sarkady F; Muszbek L; Bereczky Z; Csiba L; Bagoly Z
Biomed Res Int; 2017; 2017():3678017. PubMed ID: 28713823
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.
Wada H; Kaneko T; Ohiwa M; Tanigawa M; Hayashi T; Tamaki S; Minami N; Deguchi K; Suzuki K; Nakano T
Am J Hematol; 1993 Oct; 44(2):101-5. PubMed ID: 8266913
[TBL] [Abstract][Full Text] [Related]
9. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
10. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
[TBL] [Abstract][Full Text] [Related]
11. Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer.
Ozyilkan O; Baltali E; Ozdemir O; Tekuzman G; Kirazli S; Firat D
Tumori; 1998; 84(3):364-7. PubMed ID: 9678618
[TBL] [Abstract][Full Text] [Related]
12. [Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].
Watanabe S; Ogihara T; Iyori S; Kaneshige H; Nomoto Y; Sakai H
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):995-9. PubMed ID: 2148199
[TBL] [Abstract][Full Text] [Related]
13. High plasma level of plasmin-alpha 2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer.
Taguchi O; Gabazza EC; Yoshida M; Yamakami T; Kobayashi H; Shima T
Clin Chim Acta; 1996 Jan; 244(1):69-81. PubMed ID: 8919202
[TBL] [Abstract][Full Text] [Related]
14. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.
Mustonen P; Lepäntalo M; Lassila R
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):244-9. PubMed ID: 9484989
[TBL] [Abstract][Full Text] [Related]
15. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691
[TBL] [Abstract][Full Text] [Related]
16. Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns.
Aoki K; Aikawa N; Sekine K; Yamazaki M; Mimura T; Urano T; Takada A
Burns; 2001 Sep; 27(6):569-75. PubMed ID: 11525850
[TBL] [Abstract][Full Text] [Related]
17. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
[TBL] [Abstract][Full Text] [Related]
18. Experimental haemorrhage and blood component transfusion in humans: no change in plasma concentration of thrombin-antithrombin complex and plasmin-antiplasmin complex.
Henriksson AE; Nilsson TK; Jansson U; Bergqvist D
Thromb Res; 1996 Jun; 82(5):409-15. PubMed ID: 8771701
[TBL] [Abstract][Full Text] [Related]
19. Significance of elevated thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex in the acute stage of nontraumatic subarachnoid hemorrhage.
Itoyama Y; Fujioka S; Takaki S; Morioka M; Hide T; Ushio Y
Neurosurgery; 1994 Dec; 35(6):1055-60. PubMed ID: 7533897
[TBL] [Abstract][Full Text] [Related]
20. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]